Corcept Therapeutics Incorporated (CORT) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $12.70B, a trailing price-to-earnings ratio of 279.8 and a free-cash-flow yield of 1.0%. Over the most recent reported fiscal year, revenue grew 12.8% and free cash flow per share fell 31.6%.